UBS ETFPlease confirm that you are resident in Germany to proceed.

ETF Comparison

UBS ETF (LU) Solactive China Technology UCITS ETF (USD) A-acc

ISIN LU2265794276
Replication Physical
Asset class Equities
Fee 0.47%

Select a fund for comparison

Name of fund

UBS (Lux) Fund Solutions – Solactive China Technology UCITS ETF

Share class

UBS (Lux) Fund Solutions – Solactive China Technology UCITS ETF (USD) A-acc

ISIN

LU2265794276

Asset Class

Equities

Fund domicile

LU

Fund type

open-end

Benchmark

Solactive China Technology Total Return Net

UCITS V

yes

Launch date

05.03.2021

Currency of share class

USD

Accounting year end

31 December

Replication methodology

Physical (Full replicated)

  • The fund generally invests in the Solactive China Technology Index USD. The relative weightings of the companies correspond to their weightings in the index.
  • The investment objective is to replicate the price and return performance of the Solactive China Technology Index USD net of fees. The stock exchange price may differ from the net asset value.
  • The fund is passively managed.

Management fee p.a.

0.47%

Flat fee p.a.

0.47%

Total expense ratio (TER) p.a.

n.a.

  • The Solactive China Technology Index NTR intends to track the performance of the 100 largest technology-driven Chinese companies which derive the majority of their revenues from various innovative business activities, including cloud computing, medical technologies, future mobility, or digital entertainment. The Index is a free float adjusted market capitalization weighted index with a security weight cap of 10%.

Please consider that this performance comparison tool serves for illustration purposes only as it allows to compare any UBS ETF regardless its fund characteristics, investment objectives. Please note that certain comparisons might be insignificant or misleading due to markets, currencies, sectors or risk exposures that might not be comparable. Neither UBS AG nor any of its affiliates, its directors, employees or agents accepts any liability for any loss or damage arising out of the use of this tool.

This publication is for your information only and is not intended as an offer or a solicitation of an offer to purchase or sell any specific products and should not be treated as giving investment advice. All information and opinions as well as any indicated prices are valid only at the time of the preparation of the information and are subject to change due to market developments any time and without prior notice. We recommend consulting an investment or tax advisor or lawyer prior to your investment. Please be aware that the products presented in this publication may not fit to the personal investment objectives, portfolio and risk profile of every individual investor.

All information and opinions expressed in this publication were obtained from sources believed to be reliable. However, no representation or warranty, expressed or implied is made to their accuracy. Please note, that UBS Deutschland AG or other companies of the UBS group (or employees thereof) may purchase or sell any financial instruments or derivatives with a corresponding underlying mentioned in this publication. Furthermore, they can act as principal respectively agent or render consulting or other services to an issuer or to companies affiliated with an issuer.

This publication is targeted neither to citizens of the United States of America or of the United Kingdom nor to any persons who have permanent residence in those jurisdictions. With regard to the products presented in this publication solely the sales brochure is legally binding which can be received from UBS Deutschland AG, P.O. Box 102042, 60020 Frankfurt/Main, upon request.

This publication may neither be altered, copied nor reproduced without the prior written consent of UBS Deutschland AG.

© UBS 2021. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.